"Lightyear" (June 17) - Pixar's "Toy Story" spinoff, about the "real-life" person that inspired the Buzz Lightyear toy, has the chance to be a major hit if families are ready to return to theaters this summer. Based on those figures, there's precedent for Universal's "Dominion" to be successful, but as with any movie right now, it's not a sure thing. "Jurassic World: Dominion" (June 10) - The first two "Jurassic World" movies earned $1.67 billion and $1.31 billion globally, respectively. It will be another test for whether older audiences will return to theaters. Paramount delayed it from its last release date in November after data showed that audience comfort in going to the movies had been declining. "Top Gun: Maverick" (May 27) - This long-delayed sequel will finally see the light of day this summer. This sequel has the benefit of the character growing in popularity since then, thanks to appearances in "Avengers: Infinity War," "Endgame," and "No Way Home." "Multiverse of Madness" will look to ride off of the recent success of the latter. "Doctor Strange in the Multiverse of Madness" (May 6) - The first "Doctor Strange" took in $232 million domestically and $678 million globally. "Doctor Strange in the Multiverse of Madness." This third entry faces an uphill battle as the pandemic continues. But the sequel, 2018's "The Crimes of Grindelwald," grossed a less impressive $655 million. "Fantastic Beats: The Secrets of Dumbledore" (April 15) - Warner Bros.' "Fantastic Beasts" franchise started out fine enough in 2016 when the first movie earned $814 million worldwide. Families returning to theaters could be the biggest factor in whether the studio gets one. With its biggest movies delayed during the pandemic aside from "A Quiet Place Part II," Paramount needs a win at the box office. It grossed $149 million domestically and $319 million worldwide off of an $85 million production budget. "Sonic the Hedgehog 2" (April 8) - The first "Sonic" movie was one of the few box-office hits to open in early 2020 before theaters shut down due to the pandemic. Sony hopes "Morbius" can continue the streak after being delayed numerous times. And of course there's "No Way Home," a joint production with Marvel Studios. The first "Venom" in 2018 was a surprise hit, earning more than $800 million worldwide. Sony's Marvel film universe has been a hot streak lately, with "Venom: Let There Be Carnage" grossing more than $200 million domestically amid the pandemic, one of three movies to do so last year. One of those is Morbius, a vampire being who is a villain of Spider-Man in the comics. "Morbius" (April 1) - Because it owns the film rights to Spider-Man, Sony owns the film rights to hundreds of Spider-Man-related Marvel characters. The latest was also from Sony: "Resident Evil: Welcome to Raccoon City" earned just $31 million worldwide. "Uncharted" (February 18) - Sony's adaptation of the hit video-game series stars Spider-Man himself Tom Holland, but his star appeal didn't help last year's massive box-office flop "Chaos Walking." "Uncharted" has the benefit of franchise recognition, but video-game movies have a long history of bombing both critically and commercially. And "Scream 4" ultimately earned just $38 million domestically, a sign that the franchise may have already lost its appeal more than a decade ago. Horror movies have largely performed well during the pandemic, but no other movies are really seeing the benefits of "Spider-Man: No Way Home's" dominance right now. The last movie in the horror franchise, "Scream 4," earned $18 million domestically in its opening weekend. "Scream" (January 14) - As of now, Paramount is moving forward with releasing its "Scream" reboot next weekend only to theaters. But there are still major releases coming to theaters that have yet to be postponed: That will still be the case this year, even moreso amid the pandemic. The early months of any year are typically slow at the box office (save for breakout hits in recent years like "Black Panther" or "Get Out"). Account icon An icon in the shape of a person's head and shoulders.
0 Comments
Leave a Reply. |